Alaunos Therapeutics Profit Margin

The latest profit margin for TCRT is -133666.67% as of June 2026. That compares with -66550.0% in the prior-year period — down 100.9% year over year. That is below the Healthcare sector average of 13.71%. Investors often review this figure alongside Alaunos Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, TCRT's profit margin moved from -66550.0% to -133666.67% — a 100.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Alaunos Therapeutics's valuation or profitability profile.

Against Healthcare companies, TCRT currently prints -133666.67% for profit margin, while the sector average sits near 13.71%. That is roughly 974997.4% below the sector mean. Large gaps often invite a closer look at Alaunos Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Alaunos Therapeutics converts resources into returns. At -133666.67%, TCRT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -66550.0% in the prior-year period — down 100.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TCRT's profit margin (-133666.67%), review year-over-year change from -66550.0%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.